Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection

AIDS

Volumn 29, Issue 5, 2015, Pages 547-557

  Su, Tanja ^a   Schouten, Judith ^a   Geurtsen, Gert J ^a   Wit, Ferdinand W ^a,b   Stolte, Ineke G ^b,c   Prins, M ^a   Portegies, Peter ^a,d   Caan, Matthan W A ^a   Reiss, Peter ^a,b,e   Majoie, Charles B ^a   Schmand, Ben A ^a,f   Van Der Valk, M ^a   Kooij, K W ^a   Van Zoest, R A ^a   Elsenga, B C ^a   Martens, M ^c   Moll, S ^c   Berkel, J ^c   Moller L ^c   Visser, G R ^c   Welling, C ^c   Zaheri, S ^e   Hillebregt, M M J ^e   Gras, L A J ^e   Ruijs, Y M C ^e   Benschop, D P ^e   Kootstra, N A ^a   Harskamp Holwerda, A M ^a   Maurer, I ^a   Mangas Ruiz, M M ^a   Girigorie, A F ^a   Van Leeuwen, E ^a   Janssen, F R ^a   Heidenrijk, M ^a   Schrijver, J H N ^a   Zikkenheiner, W ^a   Wezel, M ^a   Jansen Kok, C S M ^a   Geerlings, S E ^a   Godfried, M H ^a   Goorhuis, A ^a   Van Der Meer, J T M ^a   Nellen, F J B ^a   Van Der Poll, T ^a   Wiersinga, W J ^a   Van Eden, J ^a   Henderiks, A ^a   Van Hes, A M H ^a   Mutschelknauss, M ^a   Nobel, H E ^a   Pijnappel, F J J ^a   Westerman, A M ^a   De Jong, J ^a   Postema, P G ^a   Bisschop, P H L T ^a   Serlie, M J M ^a   Lips, P ^g   Dekker, E ^a   De Rooij, S E J A ^a   Willemsen, J M R ^a   Vogt, L ^a   Ter Stege, J A ^a   Klein Twennaar, M ^a   Van Eck Smit, B L F ^a   De Jong, M ^a   Richel, D J ^a   Verbraak, F D ^a   Demirkaya, N ^a   Visser, I ^a   Ruhe H G ^a   Nieuwkerk, P T ^a   Van Steenwijk, R P ^a   Dijkers, E ^a   Van Lunsen, H W ^a   Nievaard, M A F ^a   Van Den Born, B J H ^a   Stroes, E S G ^a   Mulder, W M C ^h   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Center for Infection and Immunity Amsterdam CINIMA   (Netherlands)

^c DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^e STICHTING HIV MONITORING   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Hiv Vereniging Nederland   (Netherlands)

Author keywords

ageing; cognitive disorders; HIV infection; HIV associated neurocognitive disorders; neuropsychological assessment

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; EXECUTIVE FUNCTION; FRASCATI CRITERIA; GISSLEN CRITERIA; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MEMORY; MOTOR PERFORMANCE; MULTIVARIATE ANALYSIS; MULTIVARIATE NORMATIVE COMPARISON; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; AIDS DEMENTIA COMPLEX; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MIDDLE AGED; PROSPECTIVE STUDY; VIROLOGY;

AIDS DEMENTIA COMPLEX; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 84926526923     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000573     Document Type: Article

References (40)

1. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-860.
2. Wada N, Jacobson LP, Cohen M, French A, Phair J, Munoz A. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol 2013; 177:116-125.
3. Weber R, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med 2013; 14:195-207.
4. Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011; 53:1130-1139.
5. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53:1120-1126.
6. Cysique LA, Brew BJ. Prevalence of nonconfounded HIVassociated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol 2011; 17:176-183.
7. Winston A, Arenas-Pinto A, Stöhr W, Fisher M, Orkin CM, Aderogba K, et al. Neurocognitive function in HIV infected patients on antiretroviral therapy. PLoS One 2013; 8:e61949.
8. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 2011; 25:561-575.
9. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007; 21:1915-1921.
10. Simioni S, Cavassini M, Annoni J-M, Rimbault Abraham A, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 2010; 24:1243-1250.
11. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75:2087-2096.
12. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69:1789-1799.
13. Gisslén M, Price RW, Nilsson S. The definition of HIVassociated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis 2011; 11:356.
14. Huizenga HM, Smeding H, Grasman RPPP, Schmand B. Multivariate normative comparisons. Neuropsychologia 2007; 45:2534-2542.
15. Schouten J, Wit F, Stolte I, Kootstra N, Van der Valk M, Geerlings S, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV Cohort Study. Clin Infect Dis 2014(in press).
16. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 1996; 67:588-597.
17. Beck A, Ward C, Mendelson M, Mochk J, Erbaugh J. Assessment of depression: the depression inventory. Arch Gen Psychiatry 1961; 4:561-571.
18. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982; 21 (Pt 1):1-16.
19. Lawton M, Brody E. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1982; 9:179-186.
20. Schmand B, LindeboomJ, van Harskamp F. Dutch adult reading test. Lisse: Swets en Zeitlinger 1992.
21. Pedersen KK, Pedersen M, Gaardbo JC, Ronit A, Hartling HJ, Bruunsgaard H, et al. Persisting inflammation and chronic immune activation but intact cognitive function in HIVinfected patients after long-term treatment with combination antiretroviral therapy. J Acquir Immune Defic Syndr 2013; 63:272-279.
22. Morgan EE, Woods SP, Smith C, Weber E, Scott JC, Grant I, et al. Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND). AIDS Behav 2012; 16:2279-2285.
23. Garvey L, Surendrakumar V, Winston A. Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. HIV Clin Trials 2011; 12:333-338.
24. Cysique LA, Moffat K, Moore DM, Lane TA, Davies NWS, Carr A, et al. HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study. PLoS One 2013; 8:e61738.
25. Bonnet F, Amieva H, Marquant F, Bernard C, Bruyand M, Dauchy F-A, et al. Cognitive disorders in HIV-infected patients: are they HIV-related? AIDS 2013; 27:391-400.
26. Devlin KN, Gongvatana A, Clark US, Chasman JD, Westbrook ML, Tashima KT, et al. Neurocognitive effects of HIV, hepatitis C, and substance use history. J Int Neuropsychol Soc 2011; 18:68-78.
27. Cattie JE, Doyle K, Weber E, Grant I, Woods SP, HIV Neurobehavioral Research Program (HNRP) Group. Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning. J Clin Exp Neuropsychol 2012; 34:906-918.
28. Pumpradit W, Ananworanich J, Lolak S, Shikuma C, Paul R, Siangphoe U, et al. Neurocognitive impairment and psychiatric comorbidity in well controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study. J Neurovirol 2010; 16:76-82.
29. Chiao S, Rosen HJ, Nicolas K, Wendelken LA, Alcantar O, Rankin KP, et al. Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV. AIDS Res Hum Retroviruses 2013; 29:949-956.
30. Sainani KL. The problem of multiple testing. PM&R 2009; 1:1098-1103.
31. Meyer A-CL, Boscardin WJ, Kwasa JK, Price RW. Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power. Neuroepidemiology 2013; 41:208-216.
32. Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 2009; 19:152-168.
33. Schretlen DJ, Munro C a, Anthony JC, Pearlson GD. Examining the range of normal intraindividual variability in neuropsychological test performance. J Int Neuropsychol Soc 2003; 9:864-870.
34. Morgan EE, Woods SP, Grant I, HIV Neurobehavioral Research Program (HNRP) Group. Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders. Arch Clin Neuropsychol 2012; 27:293-303.
35. Castelli L, Rizzi L, Zibetti M, Angrisano S, Lanotte M, Lopiano L. Neuropsychological changes 1-year after subthalamic DBS in PD patients: a prospective controlled study. Parkinsonism Relat Disord 2010; 16:115-118.
36. González-Redondo R, Toledo J, Clavero P, Lamet I, García-García D, García-Eulate R, et al. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease. Eur J Neurol 2012; 19:1100-1107.
37. Chan LG, Kandiah N, Chua A. HIV-associated neurocognitive disorders (HAND) in a South Asian population: contextual application of the 2007 criteria. BMJ Open 2012; 2:e000662.
38. Cristiani SA, Pukay-Martin ND, Bornstein RA. Marijuana use and cognitive function in HIV-infected people. J Neuropsychiatry Clin Neurosci 2004; 16:330-335.
39. Chang L, Cloak C, Yakupov R, Ernst T. Combined and independent effects of chronic marijuana use and HIV on brain metabolites. J Neuroimmune Pharmacol 2006; 1:65-76.
40. Van Holst RJ, Schilt T. Drug-related decrease in neuropsychological functions of abstinent drug users. Curr Drug Abuse Rev 2011; 4:42-56.